- Deltex Medical Group, a global leader in oesophageal Doppler monitoring, has been granted a new patent. Deltex Medical has been granted patent coverage for its innovative combined blood flow and blood pressure monitor.

The granted coverage is for the UK, Germany, France, Spain and Sweden.

Coverage in the US has been 'allowed' at this stage and the company expects the US patent to be formally granted in the second half of the year. The device filing covers use of Doppler measurements of central blood flow, measured with either oesophageal or suprasternal ultrasound probes, in conjunction with blood pressure signals whether measured in arteries, veins or by way of non invasive pressure cuffs placed on the arm or fingers.

The coverage also includes the combination of a venous oxygen saturation sensor with the flow and pressure measurements.

Story provided by